Search

everythinglearnresearchcommunity

for

Search:↓

Early treatment with azithromycin and other drugs reduced COVID-19 symptoms and complications.

Human placenta hydrolysates help treat various diseases and aid healing.

Quinoline alkaloids from Cinchona may help treat cancer, diabetes, fungal infections, and promote hair growth.

COVID-19 patients may experience hair loss, but it's not linked to their age or sex.

The review found that COVID-19 can cause skin problems, including rashes and issues from wearing PPE, and suggests more research and protective measures for healthcare workers.

A COVID-19 patient had unusual nail discoloration and nail separation possibly due to the virus's effects on small blood vessels.

More people are searching for hair transplants online, preferring Follicular Unit Excision over Follicular Unit Transplant. There's also a rise in female patients and interest in beard, eyebrow transplants, and non-surgical treatments like platelet rich plasma.

Some alopecia treatments might help treat COVID-19, but more research is needed.

Cepharanthine may help treat lung fibrosis by affecting certain immune cells.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

Phyllanthus emblica leaves show potential for developing new antimalarial drugs with low toxicity.

A man experienced hair loss after getting COVID-19, which improved with treatment and might have been triggered by stress related to the illness.

Using existing drugs for new treatments is cost-effective and safer.

Women with PCOS have higher renin and d-dimer levels, especially if they have COVID-19.

The letter is skeptical about the effectiveness of anti-androgen therapy for COVID-19 and calls for strong evidence from clinical trials.

Alstonia boonei phytochemicals show promise as alternative treatments for BPH with fewer side effects than current drugs.

High incidence of hair loss found in COVID-19 patients, but no severity correlation established.

Recreational drug use can cause misdiagnosed conditions and drug interactions in HIV patients.

Non-hospitalized COVID-19 patients often have lingering symptoms for at least 30 days.

Adiantum capillus-veneris may help with respiratory issues, but more research is needed.

After severe COVID-19, 71% of patients experienced excessive hair shedding and thinning within 3 months due to factors like low oxygen levels, medication, stress, and autoimmune disease.

Women with conditions like PCOS may have a higher risk of COVID-19, but treatments like isotretinoin could help those with acne.

Many doctors lack knowledge about COVID-19 skin symptoms and need better education and guidelines.

More research is needed to understand sex and racial differences in long COVID.

The skin is vital for protection, temperature control, fluid balance, immunity, and sensing, with damage affecting daily life and mental health.

Cosmeceuticals are important for managing skin issues during the COVID-19 pandemic.

Many patients experienced hair loss after COVID-19, with women affected more, starting on average 49 days post-infection.

Social media data can help track and predict COVID-19 symptoms and trends.

Hormonal status from androgen deprivation therapy may affect COVID-19 severity in men.

The pandemic caused new skin problems in children, mainly due to mask-wearing and stress.